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2 Abstract 25
Hematopoietic Stem Cells (HSCs) located in adult bone marrow or fetal liver in mammals 26 produce all cells from the blood system. At the top of the hierarchy are long-term HSCs 27 endowed with lifelong self-renewal and differentiation properties. These features are 28 controlled through key microenvironmental cues and regulatory pathways such as Wnt 29 signaling. We have previously shown that PTK7, a tyrosine kinase receptor involved in 30 planar cell polarity (PCP), plays a role in epithelial Wnt signaling. However, its function in 31 hematopoiesis has remained unexplored. Here we show that PTK7 is expressed by 32 hematopoietic stem and progenitor cells (HSPCs) with the highest protein expression level 33 found on HSCs. Taking advantage of a Ptk7 deficient mouse strain, we demonstrate that 34 loss of Ptk7 leads to a diminished pool of HSCs, but does not affect in vitro or in vivo 35 hematopoietic cell differentiation. This is correlated with increased quiescence and reduced 36 homing capacities of Ptk7 deficient HSPCs, unravelling novel and unexpected functions for 37 planar cell polarity pathways in HSC fate. Molecules) can further subdivide this compartment (1) (2). Indeed, CD150 + CD48 -LSK have 52 been shown to contain around 40% of HSCs with long-term reconstitution potential in BM 53 as well as in FL (3). 54
Hematopoiesis is a highly controlled multi-step process that relies on complex 55 interaction networks involving cell surface receptors, growth factors, and adhesion 56 molecules expressed by HSCs and their environment (4)(5)(6)(7)(8). Because HSCs 57 generate mature hematopoietic cells, including immune cells, their replacement must be 58 adjusted to homeostatic or stress conditions such as infections, inflammation or blood loss, 59
and their expansion must be controlled to avoid exhaustion. This control is made possible 60 by the coordinated regulation of quiescence, self-renewal, and differentiation through 61 appropriate signals delivered by functional BM niches (9). HSCs are retained in these BM 62 niches by cell surface molecules endowed with adhesive and/or signalling functions 63 expressed by HSCs. These receptors belong to different protein families: integrins (VLA-4) 64 (10), Immunoglobulin superfamily (Ig Sf) adhesion molecules (6) (11), G Protein Coupled of PTK7 can be released from the plasma membrane following the sequential cleavage of 82 the receptor by membrane type 1-matrix metalloproteinase (MT1-MMP)/ADAM-17, and γ-83 secretase, interfering with its PCP and promigratory activities (24)(28)(29). 84
We have recently found that PTK7 expression is not restricted to epithelial cells. 85
Indeed, PTK7 is expressed at the cell surface of human hematopoietic progenitors and acute 86 myeloid leukemia (AML) patient blast cells. Overexpression of the PCP protein leads to 87 increased cell survival and cell migration of leukemic cells and confers a poor prognosis to 88 patients independently of other risk factors (27) . Similar conclusions were recently drawn 89
5 from studies done in chronic lymphocytic leukemia in which a set of PCP proteins is 90 upregulated (30). 91
Although functions of canonical and non-canonical Wnt pathways have been 92 extensively studied in hematopoiesis (for review see (31)(32)(33)), the role of PTK7 has 93 never been explored in this process. In the present study, we have thus addressed the 94 function of PTK7 in physiological hematopoiesis using a mouse model deficient for ptk7 95 expression. Using flow cytometry, we first mapped expression of PTK7 on HSCs and 96 progenitors. As PTK7 deficient mice die perinatally, we then studied function of PTK7 in 97 fetal hematopoiesis and revealed a decreased number of HSPCs in FL of Ptk7 deficient 98 mice. Although HSC differentiation was not affected, we found a dramatic decrease in 99 proliferation and migration properties of Ptk7 deficient HSPCs that reveal novel unexpected 100 functions for this planar cell polarity molecule. 101
102
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Methods 103
Mice 104 C57BL/6 and C57BL/6-CD45.1 were purchased from Janvier Laboratory and Charles River 105 Laboratories, respectively. All mice used for transplantation experiments are 6 to 12 weeks 106 old. Lethal irradiation was done with an X-ray irradiator (X-RAD® 160 X-Ray, PXi) using 107 a single dose of 8Gy. 108 PTK7 gene-trap mice were obtained by injection of gene-trap ES XST087 (Bays Genomics, 109 USA) in E3.5 blastocyst from C57BL/6 mouse. Chimeric mice were back-crossed with B6 110 mice for seven generations to obtain homogenous genetic background for experiments. All 111 mice were housed and maintained under specific pathogen-free condition. E14.5 and 15. 
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For analysis of hematopoietic stem/progenitor cells in BM, thymus or blood cells obtained 127 from adult mice were suspended in PBS-2% FCS. For BM and thymus, cells were filtered 128 using 70 µm cell strainer (BDFalcon) and lysis of red blood cells was done using ACK lysis 129 buffer (0.15 M NH4Cl, 10mM KHCO3, 0.1mM Na2EDTA, Life Technology) for 2 min at 130 room temperature. Cells were spun and resuspended in PBS-2%FCS +/-0.125mM EDTA 131 for staining. For blood samples, red blood cell lysis was done after staining using BD FACS 132
Lysing buffer solution (BD Biosciences) following manufacturer instructions. 133
For flow cytometry analysis and cell sorting, cells were stained with monoclonal antibodies 134 purchased from Ebiosciences or Biolegend against the following molecules: B220 (clone 135 6B2), CD3 (145-2C11), CD4 (RM4-5), CD8 (53-6.7), CD11b/Mac-1 (M1/70), CD11c 136 (N418), CD16/32 (93), CD19 (6D5), CD24 (M1/69), CD34 (RAM34), CD45 (30F11), 137 cells/well 1 day before the assay. MS5 is a stromal cell line that has been generated by 213 irradiating adherent cells in long-term BM culture. Lin Neg FL cells (5.10 5 ) obtained as 214 previously described were cocultured for 2 hours with MS5 stromal cells. Plates were 215 washed 3 times with PBS and adherent cells were removed by strong pipetting in PBS 216 1.25mM EDTA 2% FCS. The phenotype of adherent cells was determined using anti-217 CD117, Sca-1, CD150, CD48, and FITC-lineage mix to exclude any residual mature cells 218 contaminating the Lin Neg preparation. Absolute numbers were measured using the HTS 219 coupled to the BD-LSR2 SORP (BD Bioscience). 220
221
Migration assays 222
Lin Neg FL cells were enriched as previously described and suspended in Iscove modified 223
Dulbecco medium (IMDM) containing 2% of bovine serum albumine. About 2.10 5 cells in 224 75 µl were loaded in 5-μm pore Transwell system (Corning Life Sciences). The lower 225
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11 chamber was filled with Serum free Media supplemented with the chemoattracting murine 226 stromal-derived factor-1 (mSDF-1α, 100 ng/mL, Peprotech). The same number of cells was 227 plated in distinct wells to be used as control for migration. Plates were then incubated 4 228 hours at 37°C, 5% CO 2 . All experiments were performed in duplicates. Cells were also 229 stained using anti-CD117, Sca-1 and streptavidin coupled to Pacific Blue as described 230 above. Absolute numbers were measured using the HTS coupled to the BD-LSR2 SORP 231 (BD Bioscience) and the migration ratio was defined as the number of migrating cells 232 between migration wells and control wells. 233
234
TF1 cell differentiation 235
Growth of the human erythroid/macrophage progenitor cell line TF1 is dependent on GM-236 CSF or IL3 and can be induced to differentiate in the presence of growth factors. TF1 cells 237 were grown in IMDM medium supplemented with 5 ng/ml GM-CSF and supplemented 238 with EPO (2 UI/ml) for erythroid differentiation. TF1 cells were infected by viral particles 239 containing shRNA against PTK7 as previously described (27). A scramble non-targeting 240 shRNA was used as a control. shRNA efficiency for PTK7 downregulation was controlled 241 by flow cytometry before and at the end of experiments. TFI cells were then differentiated 242 in IMDM with 2 IU/ml EPO and without GM-CSF for a total of seven days as previously 243 described (35). Erythroblastic differentiation was evaluated by glycophorin A expression. 244 245
Statistical analysis 246
Statistical significance was determined with nonparametric Mann-Withney U test using 247 Prism Version 5 software (Graphpad Software Inc). 248
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Results 250
251
PTK7 is expressed on HSCs, myeloid progenitors, lymphoid and thymic progenitors 252
In a first approach, we studied PTK7 pattern of expression in adult murine hematopoietic 253 cells. To this end, a rabbit polyclonal antibody generated against the extracellular region of 254 PTK7 was used. This antibody recognizes mouse PTK7 endogenously expressed on 255 endothelial and hematopoietic cells by FACS analysis in wild type but not ptk7 deficient 256 mice ( Supplementary Fig. S1 ). Analysis of PTK7 expression in peripheral blood and in 257 splenocytes revealed that none of the mature mouse leukocytes subsets (granulocytes, 258 monocytes, B cells and T cells) expressed PTK7 to detectable level ( Fig. 1A and data not 259 shown). We next analysed PTK7 expression in murine BM hematopoietic progenitors using 260 multiparametric flow cytometry and gating strategies described in Figure 1B Supplementary Fig. S2 ). PTK7 expression is also detected on DP thymocytes before 276 becoming progressively lost at the SP stage. Altogether, these phenotypic analyses reveal 277 that PTK7 expression is inversely correlated to hematopoietic differentiation with the 278 highest expression found in HSCs. This suggests that PTK7 may play a role at this early 279 stage of hematopoietic differentiation. 280 281 Ptk7 -/embryos have a quantitative defect of hematopoietic stem cells 282
We next questioned the function of PTK7 in hematopoiesis. To this end, we generated a 283
Ptk7 deficient mouse strain using a gene-trapped ES cell available through the International 284 Gene Trap Consortium. As expected from the previous description of Ptk7 deficient strains, 285
we observed a perinatal lethality due to profound developmental defects (21). Ptk7 -/-286 embryos harbour a severe phenotype with cranial neural tube closure defect, gastroschisis, 287 kidney and forelimb abnormalities ( Fig. 2A, 2B ). Considering this dramatic phenotype, it 288 was impossible to study adult hematopoiesis in these mice and we thus decided to study FL 289 hematopoiesis. In FL, as well as in the BM, HSCs are comprised within the LSK cell 290 compartment. Using the same gating strategy as in Figure 1 , we analysed the consequences 291 of PTK7 deficiency in the different LSK cell populations ( Fig. 2C ). We observed a 25% 292 decrease of total cellularity at E14.5 in PTK7 deficient FL compared to wild type FL ( Fig.  293 2D). However proportion of leucocytes (e.g. CD45+ cells) is equivalent between deficient 294 and wild type FL ( Fig. 2E ) suggesting that the decrease in FL cellularity in Ptk7 -/embryos 295 is likely due to a global effect of ptk7 deficiency on FL size. We next examined the 296 hematopoietic progenitor compartment. A decrease of about 50% of LSK cell frequency 297 was observed in Ptk7 deficient FL compared to control FL (1.33% Ptk7 +/+ and +/-LSK 298 cells versus 0.67% Ptk7 -/-LSK cells) ( Fig. 2F ). In the different LSK cell populations, the 299
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14 most affected one was the HSC-MPP1 subset ( Fig. 2C and 2G ). No significant difference in 300 the frequency of MMP2 and MPP3-MPP4 subsets was observed in Ptk7 deficient FL 301 compared to wild type or heterozygous FL. When we examined the absolute number of the 302 different subsets of hematopoietic progenitors, we noticed that all LSK subsets were 303 affected by PTK7 deficiency. Indeed, there was a 68% decrease in the LSK cell absolute 304 number in Ptk7 deficient embryos compared to control embryos (Fig. 2H ). The most 305 dramatic decrease was observed in the HSC compartment. Indeed, there was up to 75% 306 decrease in HSC number in Ptk7 -/embryos compared to control one whereas there was 307 around a 50% decrease in MPP2 and MPP3/4 cell numbers ( Fig. 2I ) 308
To assess the frequency of functional HSC in FL, we transplanted 1000 and 400 sorted LSK 309 cells from Ptk7 +/+ or Ptk7 -/-FL bearing the CD45.2 allele into two groups of lethally 310 irradiated mice bearing the CD45.1 allele. As expected, all mice included in the group 311 injected with 1000 LSK cells survived. However, with 400 injected cells, Ptk7 +/+ FL LSK 312 cells were able to reconstitute recipient mice between 2 and 12 weeks after injection 313 whereas all mice except one injected with Ptk7 -/-LSK cells died within 6 weeks ( Fig. 2J) . 314
We concluded that loss of PTK7 leads to a defect in functional HSC frequency. In vitro 315 clonogenicity assays confirmed the defect in HSCs and early precursor frequency as we 316 observed a twofold reduction in colony-forming units starting from 3.10 4 total FL cells. 317 ( Fig. 2K) . 318
319
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PTK7 deficient fetal liver cells are more quiescent than wild type fetal liver cells 320
To determine if the absence of PTK7 could alter HSC quiescence, we performed cell cycle 321 phenotypic analysis of LSK FL cells using an antibody directed against Ki-67, a nuclear 322 marker to measure cell cycle, and DAPI to evaluate the DNA content (Fig. 3A) . We found 323 that a greater proportion of HSCs and early progenitors were in G0 phase in Ptk7 deficient 324 embryos as compared to control. Indeed, 56% of HSC-MPP1 cells were quiescent in Ptk7 325 deficient embryos with respect to 46% in control embryos (Fig. 3B ). This significant 326 increase in quiescent cells was maintained throughout hematopoietic differentiation with 327 respectively 46% versus 39% and 19% versus 14% of the cells in G0 phase at the MMP2 328 and MPP3-MPP4 stages (Fig. 3B ). To exclude that these unbalanced proportion of 329 quiescent cells was not due to selective apoptosis of cycling Ptk7 deficient cells, we 330 analyzed the percentage of apoptotic cells in Ptk7 deficient and control FL cells. We did not 331 observed a difference of apoptosis as measured by Annexin V staining between wild type 332 and mutant mice in total FL cells and LSK cells (Fig. 3C ). These results demonstrate that 333 PTK7 delivers proliferative signals to HSCs but does not affect HSC survival. 334 335 PTK7 deficient cells are able to reconstitute definitive hematopoiesis in recipient mice 336
To investigate the functional capacity of Ptk7 deficient HSCs, we generated chimeric mice 337 using FL cell transplantation. CD45.1 C57Bl/6 mice were lethally irradiated (8 Gy) and 338 then reconstituted with 3.10 6 total FL cells from Ptk7 deficient or wild type FL embryos 339 (CD45.2). Reconstitution and chimerism were followed over time by monitoring the 340 frequency of donor cells (CD45.2) versus recipient cells (CD45.1) in the peripheral blood 341 of recipient mice (Fig. 4A) . As expected, all recipient mice injected with control FL cells 342 were reconstituted between 2 and 12 weeks. The same results were obtained with PTK7 343 deficient FL cells demonstrating that in absence of any competition, Ptk7 deficient HSCs 344 16 are able to reconstitute all mature hematopoietic lineages of lethally irradiated recipients 345 ( Fig. 4B-C) . To investigate whether Ptk7 deficiency could lead to more subtle 346 hematopoietic defects, BM of chimeric mice was analyzed after twelve weeks. No 347 significant difference was found in frequencies of mature and progenitor cells in the BM 348 ( Fig. 4E-F) . In agreement with reconstitution experiments, in vitro differentiation assays 349 showed that Ptk7 deficient FL cells are able to give rise to all subtypes of colony forming 350 units in the same proportion than control FL cells (Fig. 4G , left panel and supplementary 351 Fig.S4 ). However, we observed fewer colonies generated by Ptk7 deficient HSPC than by 352 control cells (Fig. 4G, right panel) . This is likely due to decreased cell cycle activity of Ptk7 353 deficient HSPCs while the potential of differentiation is not affected. Since quiescence of 354
HSCs could be correlated to loss of self-renewal (36), we then tested self-renewal capacities 355 of Ptk7 deficient HSCs by serial transplantation assays. Recipient CD45.1 mice were 356 lethally irradiated and reconstituted with CD45.2 donor cells from wild type and mutant 357 mice. The first injection was performed with 3.10 6 total FL cells. After 12 weeks, BM cells 358 were harvested and 3.10 6 cells were then injected to a second lethally irradiated recipient. 359
The same protocol was applied for the following transplantations. We monitored chimerism 360 by flow cytometry analysis and obtained a very good reconstitution with about 95 to 100% 361 of donor cells in BM for all transplantations (Fig. 4H ). We also investigated erythroblastic 362 reconstitution in mice and did not find any differences in term of hemoglobin level and red 363 blood cell count ( Supplementary Fig. S3A and S3B) . In vitro differentiation using TF1 cells 364 that are able to differentiate in response to EPO did not reveal any difference in the 365 presence or absence of PTK7 ( Supplementary Fig. S3C and S3D ). We thus concluded that 366 PTK7 is not required for hematopoietic differentiation. 367
To get further insights into PTK7 function in early hematopoiesis, we performed mixed 368 chimera competition experiments. CD45.1 C57Bl/6 mice were lethally irradiated (8 Gy) 369 17 and then reconstituted with 2.10 6 total FL cells from Ptk7 deficient (CD45.2) and 2.10 6 total 370 FL cells from wild type FL embryos (CD45.2xCD45.1). Reconstitution and chimerism 371 were followed over time by monitoring the frequency of PTK7 -/cells (CD45.2) and 372 PTK7 +/+ (CD45.2 + CD45.1 + ) versus recipient cells (CD45.1) in the peripheral blood of 373 recipient mice. We did not observe significant differences at D30 and D60, but observed an 374 advantage of PTK7 -/cells at long term (>120 jours) (Fig. 5A ). Since maintenance of 375 quiescence is a stem cell property, we tested cell cycle activity of adult HSC in chimeric 376 mice. Recipient CD45.1 mice were lethally irradiated and reconstituted with CD45.2 donor 377 cells from wild type and mutant FL mice as previously described. We performed cell cycle 378 analysis on hematopoietic progenitors more than 6 months post transplantation, when stable 379 hematopoietic reconstitution is obtained. We confirmed that hematopoietic progenitors 380 isolated from mice reconstituted with PTK7 deficient cells are more quiescent than wild 381 type counterparts ( Fig. 5B and 5C) . Clonogenic experiments confirmed that fewer colonies 382 are generated by Ptk7 deficient HSPC than by control from chimeric mice (Fig. 5D ). These 383 results suggest that PTK7 is essential for quiescence independently of the 384 microenvironment. 385 386
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Homing and migration defects of Ptk7 deficient cells 387
Since we have previously described a pro-migratory function of PTK7 in leukemic cell 388 lines and because increased HSC quiescence may not be the unique cause of the functional 389 defect of Ptk7 -/-HSCs (Fig. 2J) , we decided to investigate the role of PTK7 in 390 hematopoietic homing. FL cells from several Ptk7 -/or Ptk7 +/+ embryos were pooled and 391 stained separately with two different fluorescent trackers. Cells were injected according to a 392 1/1 ratio and mice were sacrificed 12h after injection. Analysis of homing was performed 393 by flow cytometry (Fig. 6A-C) . Although we observed comparable levels of residual 394
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18 circulating cells regardless the PTK7 status in peripheral blood, Ptk7 deficient cells had a 395 very poor capacity to home to the BM, spleen, liver, and thymus as compared to control 396 ( Fig. 6D ). Since homing defect can be explained by loss of cell adhesion to BM stromal 397 cells and/or by a defect of cell migration toward a chemoattractant, we tested these two 398 hypotheses. Adhesion of Ptk7 deficient LSK cells on the murine MS5 stromal cell line was 399 not significantly different from control LSK cells (Fig. 7A) . In contrast, we found a 400 decrease in spontaneous transmigration of Ptk7 deficient FL cells as compared to control 401 cells in Boyden chamber assay (8% versus 5%, Fig. 7B ). No effect was observed with 402 heterozygous FL cells. We also observed significant differences when the chemokine 403
SDF1α was used as a chemoattractive molecule. Indeed, whereas 12% of control FL cells 404 migrated toward SDF1α, only 8% of PTK7 deficient FL cells were able to do so (Fig. 7C) . 405
Without chemoattractant, less than 5% of LSK cells migrated across the transwell 406 regardless the PTK7 status (Fig. 7D) . When SDF1α was used as a chemoattrative molecule, 407 a twofold decrease in LSK transmigration was observed for Ptk7 deficient cells as 408 compared to control cells (20% versus 40%, Fig. 7E ). 409 410 411
19
Discussion 412
Discovery of novel molecular pathways implicated in HSC maintenance is of 413 particular interest to develop new strategies aiming at the regeneration of damaged 414 hematopoietic tissues and to understand hematopoietic diseases such as leukemia. We have 415 previously identified the cell polarity protein, PTK7, as a novel tyrosine kinase receptor 416 overexpressed in acute myeloid leukemia (AML). High expression of PTK7 is correlated to 417 poor prognosis and resistance to chemotherapeutic regimens (27). Recently, another study 418 revealed that PTK7 is also upregulated in T acute lymphocytic leukemia (T-ALL)(37). In 419 humans, we and others have evidenced that PTK7 expression is mostly restricted to normal 420 early progenitors committed to myeloid and T lymphoid lineages. 421
In the present study, we show that PTK7 expression is similar between mouse and 422 human systems. PTK7 is absent in mature blood cells and its expression in BM 423 hematopoietic progenitors is inversely correlated with differentiation. The highest 424 expression of PTK7 is found in HSC-MPP1 compartment. PTK7 expression is also 425 conserved between mice and human when the thymic compartment is considered. PTK7 is 426 easily detectable at the cell surface of CLP and immature DN and DP populations whereas 427 its expression is lost in single positive CD4 or CD8 lymphocytes. These data correlate with 428 results from other groups that demonstrated expression of PTK7 by recent thymic emigrants 429 cells and thymocytes (38)(37). 430
In order to study the role of PTK7 in hematopoiesis, we generated Ptk7 deficient mice using 431 available gene-trapped ES cells. Our Ptk7 deficient strain exhibited expected planar cell 432 polarity defects as compared to another strain of mice issued from the same ES clone (21). 433
Since these mutant mice cannot reach adulthood, functions of PTK7 were investigated in 434 FL hematopoietic cells. The major hematopoietic phenotype of Ptk7 deficient mice consists 435 in increased quiescence of HSPCs and shrinkage of the FL HSPC pool. Although these 436 20 phenotypes may sound logical if one considers that less proliferation produces less cells, 437 they are difficult to reconciliate with loss of functional reconstitution observed when 438 recipient mice are engrafted with limited numbers of LSK cells (Fig. 2J) . Indeed, PTK7 is 439 implicated in canonical and non-canonical Wnt pathway (17)(39), which are thought to be 440 the guardians of the balance between HSC self-renewal and HSC differentiation (32). We HSCPs using a candidate gene/protein approach. We also looked at gene expression 457 differences between Ptk7 knock-out and control hematopoietic cells using unbiased gene 458 expression profiling. Although we identified differences (data not shown), we could not 459 find obvious Gene Ontology enrichments or pathways that could be experimentally tested. 460
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Further studies will be needed to unravel how Ptk7 functions in HSPCs. 461
21
In our model of FL hematopoietic cells, we confirmed the role of PTK7 in cell 462 migration and found a new role of this protein in cell homing to hematopoietic organs and 463 in the control of cell proliferation. This observation confirms our previous data obtained 464 from human leukemia samples (27) can be linked with already described functions of PTK7 465 in cell migration and in metastatic dissemination. Indeed, we and others have found that 466 PTK7 expression on various cancer cells is linked with higher metastasis potential 467 (27)(29)(48)(49). Recently, we also described a poor prognosis of PTK7 expression in 468 colon cancer cells linked with higher metastatic events (50). In addition, our data show for 469 the first time that PTK7 is involved in the regulation of hematopoietic and stem and 470 progenitors cell (HSPC) cycle. Lack of PTK7 expression increases quiescence and 471 enhances the long term repopulating potential after six months, while a trend toward 472 decreased chimerism is observed after one or two months. This could reflect the dual 473 function of PTK7 loss of expression in decreasing short term homing to the bone marrow 474 and increasing long term establishment of hematopoiesis. Alternatively, it may well be that 475 homing assay performed with total liver cells reveals a constitutive promigratory function 476 of PTK7, in contrast to long term engraftment reflecting bone marrow micro-environmental 477 signaling through PTK7 in HSCs. Similar complex mechanisms of cell cycle regulation and 478 differential homing of mature cells versus HSPCs homing to the bone marrow have also 479 been attributed to CXCR4 (51) (52) (53) (54). Whether PTK7 and CXCR4 signaling share 480 more in common remains to be addressed. In conclusion, PTK7 overexpression in 481 immature blasts cells of acute myeloid leukemia has been associated to bad prognosis, early 482 relapse and chemotherapeutic resistance and a recent study shows that PTK7 can be used as 483 a stem cell marker of colon cancer stem cells (27)(55). Taken together, all these data form a 484 set of arguments to involve PTK7 expression in stem cells including cancer stem cells but 485 also to prove a functional role of PTK7 in stem cell biology. We think that these new data 486 
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